Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Oncotarget|September 15, 2017
CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent mannerHadjer Abdelouahab, Yanyan Zhang, Monika Wittner, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2015
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin LymphomaBastian von Tresckow, Franck Morschhauser, Vincent Ribrag, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin LymphomaLayal El Halabi, Julien Adam, Pauline Gravelle, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Phase I study assessing the safety and tolerability of barasertib (AZD1152) with low-dose cytosine arabinoside in elderly patients with AMLHagop M Kantarjian, Mikkael A Sekeres, Vincent Ribrag, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 10, 2017
18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint InhibitorLaurent Dercle, Romain-David Seban, Julien Lazarovici, et al.
Cancer Research|December 15, 2010
Cyclophosphamide induces differentiation of Th17 cells in cancer patientsSophie Viaud, Caroline Flament, Mustapha Zoubir, et al.
Blood|June 22, 2012
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'AdulteRichard Delarue, Corinne Haioun, Vincent Ribrag, et al.
Transplantation and Cellular Therapy|March 5, 2025
Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab TherapyJohn Kuruvilla, Philippe Armand, Alex F Herrera, et al.
Pageof 21